Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04696159 · ClinicalTrials.gov registry record · NA

Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes

A NA study of Diabetes Mellitus and Gastroparesis, sponsored by Matthew Allemang.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04696159 is a NA study of Diabetes Mellitus and Gastroparesis that is actively recruiting participants, run by Matthew Allemang. The registered enrollment target is 40 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04696159, a NA study of Diabetes Mellitus and Gastroparesis, is actively recruiting participants, sponsored by Matthew Allemang.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

Interventions

  • PROCEDURE Pyloromyotomy

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-01-04
Est. Completion 2027-06
Phase NA

Sponsor

Matthew Allemang

2 total trials

What the Registry Record Tells You About NCT04696159

The ClinicalTrials.gov registry entry for NCT04696159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The listed sponsor is Matthew Allemang, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Pyloromyotomy is the first listed.

NCT04696159 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04696159 about?

NCT04696159 is a clinical study titled "Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes". This study will assess changes in glycemic control in 40 patients with diabetes who undergo per-oral pyloromyotomy (POP) for medically refractory gastroparesis.

What is the current status of trial NCT04696159?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-01-04. Estimated completion is 2027-06.

What conditions does trial NCT04696159 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Gastroparesis, Gastroparesis With Diabetes Mellitus.

What interventions are being tested in trial NCT04696159?

The interventions under investigation include: Pyloromyotomy (PROCEDURE).

Who is sponsoring clinical trial NCT04696159?

This trial is sponsored by Matthew Allemang, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04696159 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.